Erratum: Mesenchymal high-grade glioma is maintained by the ID-RAP1 axis (The Journal of Clinical Investigation (2013) 123:1 (405-417) (DOI: 10.1172/JCI63811);Mesenchymal high-grade glioma is maintained by the ID-RAP1 axis

Journal of Clinical Investigation

Volumn 123, Issue 1, 2013, Pages 405-417

  Niola, Francesco ^a,h   Zhao, Xudong ^a,g   Singh, Devendra ^a   Sullivan, Ryan ^a   Castano, Angelica ^a   Verrico, Antonio ^a   Zoppoli, Pietro ^a   Friedmann Morvinski, Dinorah ^b   Sulman, Erik ^c   Barrett, Lindy ^d   Zhuang, Yuan ^e   Verma, Inder ^b   Benezra, Robert ^d   Aldape, Ken ^c   Iavarone, Antonio ^a,f   Lasorella, Anna ^a,f  

^a New York Presbyterian Morgan Stanley Children's Hospital   (United States)

^b SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

^f Department of Neurology ^*  (United States)

^g KUNMING INSTITUTE OF ZOOLOGY   (China)

^h ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INHIBITOR OF DIFFERENTIATION 1; INHIBITOR OF DIFFERENTIATION 2; INHIBITOR OF DIFFERENTIATION 3; RAP1 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CANCER MODEL; CANCER PATIENT; CANCER SURVIVAL; CARCINOGENESIS; CELL ADHESION; CONTROLLED STUDY; EMBRYO; GENE DELETION; GENE INACTIVATION; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; MESENCHYMAL HIGH GRADE GLIOMA; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATOR GENE; SIGNAL TRANSDUCTION; STEM CELL NICHE; TUMOR ABLATION; TUMOR REGRESSION;

EID: 84873820704     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI77927     Document Type: Erratum

References (56)

1. Ohgaki H, Kleihues P. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol. 2005;64(6): 479-489.
2. Park DM, Rich JN. Biology of glioma cancer stem cells. Mol Cells. 2009;28(1): 7-12.
3. Stiles CD, Rowitch DH. Glioma stem cells: a midterm exam. Neuron. 2008;58(6): 832-846.
4. Calabrese C, et al. A perivascular niche for brain tumor stem cells. Cancer Cell. 2007;11(5): 69-82.
5. Charles N, et al. Perivascular nitric oxide activates notch signaling and promotes stem-like character in PDGF-induced glioma cells. Cell Stem Cell. 2010; 6(2): 141-152.
6. Lathia JD, et al. Integrin alpha 6 regulates glioblastoma stem cells. Cell Stem Cell. 2010;6(5): 421-432.
7. Venere M, Fine HA, Dirks PB, Rich JN. Cancer stem cells in gliomas: identifying and understanding the apex cell in cancer's hierarchy. Glia. 2011; 59(8): 1148-1154.
8. Lathia JD, Heddleston JM, Venere M, Rich JN. Deadly teamwork: neural cancer stem cells and the tumor microenvironment. Cell Stem Cell. 2011; 8(5): 482-485.
9. Perk J, Iavarone A, Benezra R. Id family of helixloop- helix proteins in cancer. Nat Rev Cancer. 2005; 5(8): 603-614.
10. Wu Y, Richard JP, Wang SD, Rath P, Laterra J, Xia S. Regulation of glioblastoma multiforme stemlike cells by inhibitor of DNA binding proteins and oligodendroglial lineage-associated transcription factors. Cancer Sci. 2012;103(6): 1028-1037.
11. Lyden D, et al. Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature. 1999;401(6754): 670-677.
12. Nam HS, Benezra R. High levels of Id1 expression define B1 type adult neural stem cells. Cell Stem Cell. 2009;5(5): 515-526.
13. Niola F, et al. Id proteins synchronize stemness and anchorage to the niche of neural stem cells. Nat Cell Biol. 2012;14(5): 477-487.
14. Vandeputte DA, et al. Expression and distribution of id helix-loop-helix proteins in human astrocytic tumors. Glia. 2002;38(4): 329-338.
15. Massari ME, Murre C. Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms. Mol Cell Biol. 2000;20(2): 429-440.
16. Anido J, et al. TGF-beta receptor inhibitors target the CD44(high)/Id1(high) glioma-initiating cell population in human glioblastoma. Cancer Cell. 2010;18(6): 655-668.
17. Jeon HM, et al. Inhibitor of differentiation 4 drives brain tumor-initiating cell genesis through cyclin E and notch signaling. Genes Dev. 2008; 22(15): 2028-2033.
18. Jin X, et al. EGFR-AKT-Smad signaling promotes formation of glioma stem-like cells and tumor angiogenesis by ID3-driven cytokine induction. Cancer Res. 2011;71(22): 7125-7134.
19. Barrett LE, et al. Self-renewal does not predict tumor growth potential in mouse models of highgrade glioma. Cancer Cell. 2012;21(1): 11-24.
20. Phillips HS, et al. Molecular subclasses of highgrade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell. 2006;9(3): 157-173.
21. Marumoto T, et al. Development of a novel mouse glioma model using lentiviral vectors. Nat Med. 2009; 15(1): 110-116.
22. Guha A, Feldkamp MM, Lau N, Boss G, Pawson A. Proliferation of human malignant astrocytomas is dependent on Ras activation. Oncogene. 1997;5(23): 2755-2765.
23. Lee J, et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell. 2006;9(5): 391-403.
24. Tropepe V, Sibilia M, Ciruna BG, Rossant J, Wagner EF, van der Kooy D. Distinct neural stem cells proliferate in response to EGF and FGF in the developing mouse telencephalon. Dev Biol. 1999;208(1): 166-188.
25. Son MJ, Woolard K, Nam DH, Lee J, Fine HA. SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma. Cell Stem Cell. 2009;4(5): 440-452.
26. Carro MS, et al. The transcriptional network for mesenchymal transformation of brain tumours. Nature. 2010;463(7279): 318-325.
27. Verhaak RG, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010;17(1): 98-110.
28. Bhat KP, et al. 2011. The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma. Genes Dev. 2011;25(24): 2594-2609.
29. Boettner B, Van Aelst L. Control of cell adhesion dynamics by Rap1 signaling. Curr Opin Cell Biol. 2009; 21(5): 684-693.
30. Bos JL, et al. The role of Rap1 in integrin-mediated cell adhesion. Biochem Soc Trans. 2003;31(pt 1): 83-86.
31. Caron E. Cellular functions of the Rap1 GTP-binding protein: a pattern emerges. J Cell Sci. 2003; 116(pt 3): 435-440.
32. Vuchak LA, Tsygankova OM, Meinkoth JL. Rap- 1GAP impairs cell-matrix adhesion in the absence of effects on cell-cell adhesion. Cell Adh Migr. 2011; 5(4): 323-331.
33. Endersby R, Zhu X, Hay N, Ellison DW, Baker SJ. Nonredundant functions for Akt isoforms in astrocyte growth and gliomagenesis in an orthotopic transplantation model. Cancer Res. 2011; 71(12): 4106-4116.
34. Bachoo RM, et al. Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis. Cancer Cell. 2002;1(3): 269-277.
35. Rothschild G, Zhao X, Iavarone A, Lasorella A. E Proteins and Id2 converge on p57Kip2 to regulate cell cycle in neural cells. Mol Cell Biol. 2006; 26(11): 4351-4361.
36. Arthur WT, Quilliam LA, Cooper JA. Rap1 promotes cell spreading by localizing Rac guanine nucleotide exchange factors. J Cell Biol. 2004;167(1): 111-122.
37. Sebzda E, Bracke M, Tugal T, Hogg N, Cantrell DA. Rap1A positively regulates T cells via integrin activation rather than inhibiting lymphocyte signaling. Nat Immunol. 2002;3(3): 251-258.
38. Freije WA, et al. Gene expression profiling of gliomas strongly predicts survival. Cancer Res. 2004; 64(18): 6503-6510.
39. Gravendeel LA, et al. Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology. Cancer Res. 2009;69(23): 9065-9072.
40. Petalidis LP, et al. Improved grading and survival prediction of human astrocytic brain tumors by artificial neural network analysis of gene expression microarray data. Mol Cancer Ther. 2008; 7(5): 1013-1024.
41. Zhang L, et al. Identification of a putative tumor suppressor gene Rap1GAP in pancreatic cancer. Cancer Res. 2006;66(2): 898-906.
42. Zhang Z, et al. Rap1GAP inhibits tumor growth in oropharyngeal squamous cell carcinoma. Am J Pathol. 2006;168(2): 585-596.
43. Zheng H, Gao L, Feng Y, Yuan L, Zhao H, Cornelius LA. Down-regulation of Rap1GAP via promoter hypermethylation promotes melanoma cell proliferation, survival, and migration. Cancer Res. 2009;69(2): 449-457.
44. Zuo H, et al. Downregulation of Rap1GAP through epigenetic silencing and loss of heterozygosity promotes invasion and progression of thyroid tumors. Cancer Res. 2010;70(4): 1389-1397.
45. Paik S, et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med. 2004;351(27): 2817-2826.
46. Paik S, et al. Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. J Clin Oncol. 2006; 24(24): 3726-3734.
47. Ablain J, Nasr R, Bazarbachi A, de The H. The drug-induced degradation of oncoproteins: an unexpected Achilles' heel of cancer cells? Cancer Discov. 2011;1(2): 117-127.
48. Guo Z, Li H, Han M, Xu T, Wu X, Zhuang Y. Modeling Sjogren's syndrome with Id3 conditional knockout mice. Immunol Lett. 2011;135(1-2): 34-42.
49. Pan L, Sato S, Frederick JP, Sun XH, Zhuang Y. Impaired immune responses and B-cell proliferation in mice lacking the Id3 gene. Mol Cell Biol. 1999;19(9): 5969-5980.
50. Zhao X, et al. The N-Myc-DLL3 cascade is suppressed by the ubiquitin ligase Huwe1 to inhibit proliferation and promote neurogenesis in the developing brain. Dev Cell. 2009;17(2): 210-221.
51. Zhao X, et al. The HECT-domain ubiquitin ligase Huwe1 controls neural differentiation and proliferation by destabilizing the N-Myc oncoprotein. Nat Cell Biol. 2008;10(6): 643-653.
52. Scherer A, ed. Batch Effects And Noise In Microarray Experiments: Sources And Solutions. Chichester, United Kingdom: J. Wiley Publisher; 2009.
53. Tomayko MM, Reynolds CP. Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother Pharmacol. 1989;24(3): 148-154.
54. Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008;455(7216): 1061-1068.
55. R Development Core Team, ed. R: A Language And Environment For Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing Publisher; 2011.
56. Venables WN, Ripley BD, Venables WN, eds. Modern Applied Statistics With S. New York, New York, USA: Springer; 2002.